Publication | Closed Access

Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies

Neoadjuvant ChemoradiotherapyEsophageal CancerMedicineCancer RecurrenceSurgeryRecurrence RiskEsophageal SurgeryOncologyRadiation OncologyPathologic StageCancer Research